Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer. - Wikidata - awgldk - TriplyDB

Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.

Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.

http://www.wikidata.org/entity/Q33907528

about

CEA in breast ductal secretions as a promising biomarker for the diagnosis of breast cancer: a systematic review and meta-analysis.CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis Clinical significance of serum CA15-3 as a prognostic parameter during follow-up periods in patients with breast cancer.The current status of heart failure diagnostic biomarkers.Postoperative recurrence analysis of breast cancer patients based on clinical serum markers using discriminant methods.Evaluation of a newly developed quantitative determination kit for tumor marker CA15-3 with chemiluminescent assay.Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.

P2860

Q35929665-DF0F4AAB-27DA-4417-A725-3150D3D7FA88 Q36135645-BD745841-ADD9-4D33-92C2-01C0644A68A9 Q36573275-0953D2E5-3417-4B10-B3EA-007459D0021D Q38703882-4B16AEBF-9984-4FB1-B512-F7D9B808BDEE Q47355374-3AEBD8AA-B7C3-46B6-B7D8-94ECE5F31C96 Q47961219-6130A65D-1573-468B-BB76-AC44EA69F321 Q55036428-FDDE02A8-5AB7-4D87-B57C-F91891AFC7BB

P2860

Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.

http://www.wikidata.org/entity/Q33907528

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Nipple discharge of CA15-3, CA ...... arker panel for breast cancer.

@ast

Nipple discharge of CA15-3, CA ...... arker panel for breast cancer.

@en

type

label

Nipple discharge of CA15-3, CA ...... arker panel for breast cancer.

@ast

Nipple discharge of CA15-3, CA ...... arker panel for breast cancer.

@en

prefLabel

Nipple discharge of CA15-3, CA ...... arker panel for breast cancer.

@ast

Nipple discharge of CA15-3, CA ...... arker panel for breast cancer.

@en

P1433

Q33907528-6847E853-3961-4571-ABBB-7FC69B909C9E

P1476

Q33907528-FBBB667C-C720-4854-B83B-E06BF6A16B46

P2093

Q33907528-59B7D848-E339-46BF-9449-D0CE55592017

Q33907528-73D4DA73-8D6A-4372-8FC8-CF8C93D1391D

Q33907528-8632EDDE-BE02-4845-A724-BE148C33EA0D

Q33907528-8DD0EDEF-DB28-4CC9-8C31-B3D84972DCE9

Q33907528-9A7BED4C-33C8-499C-A7FA-791D5592ADB9

Q33907528-A2607B63-ED46-4E8D-B6CC-A0CBDE5CCB24

Q33907528-A55E381E-AF8E-47C1-A79B-C8725EEECF66

Q33907528-B95E1D6F-3C5B-4A46-8204-0EF1EDEDBA32

P2860

Q33907528-20E9D174-94CE-4D67-B6D9-CBC259575872

Q33907528-270F9648-5C8A-4394-BCB7-CB729417511B

Q33907528-31EB34CD-ED5B-458E-9033-19350D9E57D8

Q33907528-33FA42C5-D0EB-4CA8-A550-202E0AA9F41A

Q33907528-3764E511-965A-460C-9712-DD25370B229E

Q33907528-44F2E328-7A9E-4977-B988-258907C85805

Q33907528-4E4C6032-FA2F-460B-A666-FFD701BAE51E

Q33907528-5D0E465D-E10D-44E5-B603-7E0BD332733F

Q33907528-5F983395-641B-44AD-9842-74D718F9B4E6

Q33907528-68304CEB-DFF5-4E23-9053-EE6F59C65A9B

P304

Q33907528-CF1F5A7F-756B-49B3-B2AD-303D0A0A0DC3

P31

Q33907528-927C7295-B039-4F32-A342-D756631AE72E

P356

Q33907528-FC0013A7-CFF5-42D7-AD23-72D74E76A496

P407

Q33907528-BCA47E66-9286-48E8-A195-72820537E50E

P433

Q33907528-D77B921D-8221-4DE3-AE0B-643FC7500BFA

P478

Q33907528-9E93FDCF-7747-489E-A16D-9F44523CBF43

P577

Q33907528-983ACDA8-6C4B-49BF-9305-35651387802B

P5875

Q33907528-B82108DD-62CB-4F53-91F5-1E4507DDC232

P698

Q33907528-50A072DF-FEEF-4FC3-8A96-03D5631276F2

P932

Q33907528-1419FCB0-01CE-4B00-9277-8A0265058DD8

P356

P1433

International Journal of Molecular Sciences

P1476

Nipple discharge of CA15-3, CA ...... arker panel for breast cancer.

@en

P2093

Gangping Wang

http://www.w3.org/2001/XMLSchema#string

Jinhui Zhao

http://www.w3.org/2001/XMLSchema#string

Junxi Zhang

http://www.w3.org/2001/XMLSchema#string

Meihua Qin

http://www.w3.org/2001/XMLSchema#string

Yan Qin

http://www.w3.org/2001/XMLSchema#string

Yanqing Sun

http://www.w3.org/2001/XMLSchema#string

Yun'ai Liang

http://www.w3.org/2001/XMLSchema#string

Zuofeng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Putative biomarkers and targets of estrogen receptor negative human breast cancer

Molecular portraits of human breast tumours

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.

Autoantibodies to tumor-associated antigens in breast carcinoma.

Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk prediction.

Proteomic serum biomarkers and their potential application in cancer screening programs.

Inhibitor of apoptosis protein-like protein-2 as a novel serological biomarker for breast cancer.

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

P304

9546-9565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS15069546

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262785171

http://www.w3.org/2001/XMLSchema#string

P698

24879526

http://www.w3.org/2001/XMLSchema#string

P932

4100109

http://www.w3.org/2001/XMLSchema#string